Vous êtes ici

Core One Labs Inc.

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
COOL
Indice CSE: 
Devise: 

Core One Labs Inc. is a research and technology company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy.  The Company has developed a patent pending thin film oral strip (the “technology”) which dissolves instantly when placed in the mouth and delivers organic molecules in precise quantities to the bloodstream, maintaining excellent bioavailability. With this technology, the Company intends to further develop its IP technology to focus on delivering psychedelic molecules with an initial focus on psilocybin. Core One also holds an interest in walk-in medical clinics which maintain a database of over 200,000 patients combined. Through research and development in these clinics, including the integration of its intellectual property related to psychedelic treatments and novel drug therapies, the Company intends to work towards regulatory approval for research that advances psychedelic-derived treatments for mental health disorders.

Vous êtes ici

Core One Labs Inc. (COOL)

SEDAR Information

Information d'entreprise

Addresse
Suite 800-1199 West Hastings Street
Vancouver, BC V6E 3T5
Canada
Téléphone
236-521-0626
Courriel
Info@core1labs.com
URL
HTTP://www.core1labs.com
Date d’inscription à la cote
Mercredi, août 17, 2011
Agent de transfert
Computershare Investor Services Inc.
Relations avec les investisseurs
Stride Report Inc.
Courriel
info@core1labs.com
Vérificateur
HDCPA Professional Corporation

Capitalisation

Capitalisation: 
47097332
Réservé à l'émission: 
4685562

Company Officers

Joel Shacker, Chief Executive Officer
Geoff Balderson, Chief Financial Officer & Corporate Secretary

Bulletins

16/08/2011

2011-0807 - New Listing - Kariana Resources Inc. (KAA)

August 16, 2011


The common shares of Kariana Resources Inc. have been approved for listing on CNSX.  Following an Initial Public Offering of 3 million shares at a price of $0.20 per share for gross proceeds of $600,000, there are 11,425,000 shares outstanding with a public float of approximately 7.4 million shares.  Canaccord Genuity Corp. acted as Agent on the Offering.